Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 601–700 of 1,021
Boufaied, N., Chetta, P., Hallal, T., Cacciatore, S., Lalli, D., Luthold, C., Homsy, K., Imada, E. L., Syamala, S., Photopoulos, C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-0519 · Cited by 62
“Toruleoutthatthemetabolic changesweobservedweresimplytheresultsofHFD-inducedchanges in cellular composition rather than features of tumor metabolism rewiring, we estimated tumor purity and cell composition using theESTIMATEandPUREEmethods(36,37).”
Zhang, J., Zhang, J., Wang, F., Xu, X., Li, X., Guan, W., Men, T., & Xu, G. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30350 · Cited by 69
“defined Tumours using Expression data (ESTIMATE) is a method that evaluates the fraction of stromal and immune cells in tumor samples using gene expression profile (Yoshihara et al., 2013).”
MethodApplicability of spatial transcriptional profiling to cancer research
Bassiouni, R., Gibbs, L. D., Craig, D. W., Carpten, J. D., & McEachron, T. A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.016 · Cited by 61
“Various computational methods have been developed to deconvolute both bulk RNA-seq and scRNA-seq datasets to identify distinct cellular populations (Aran, Hu and Butte, 2017; Newman et al., 2015; Newman et al., 2019; Yoshihara et al., 2013; Abdelaal et al., 2019; Menden et al., 2020).”
MethodPrimary tumour immune response and lymph node yields in colon cancer
Lal, N., Chan, D. K. H., Ng, M. E., Vermeulen, L., & Buczacki, S. J. A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01700-1 · Cited by 59
“The Estimate immune signature and xCell cell-type signatures were next used to independently confirm the apparent high immune response in tumours with high LN yield and explore whether specific subsets of immune cells were enriched in these tumours [29, 30].”
MethodWang, K., Patkar, S., Lee, J. S., Gertz, E. M., Robinson, W., Schischlik, F., Crawford, D. R., Schäffer, A. A., & Ruppin, E. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0887 · Cited by 55
Bassaganyas, L., Pinyol, R., Esteban-Fabró, R., Torrens, L., Torrecilla, S., Willoughby, C. E., Franch-Expósito, S., Vila-Casadesús, M., Salaverria, I., Montal, R., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1497 · Cited by 58
“To this end, we correlated the BSs and FSs from 10,635 TCGA samples representing 27 tumor types with a transcriptomic surrogate of the immune infiltrate level: the immune score from the ESTIMATE tool (28).”
BackgroundMethodGenomics and the Immune Landscape of Osteosarcoma
Wu, C.-C., & Livingston, J. A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43085-6_2 · Cited by 58
Arora, A., Patil, V. S., Kundu, P., Kondaiah, P., Hegde, A. S., Arivazhagan, A., Santosh, V., Pal, D., & Somasundaram, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39067-8 · Cited by 60
De novo compartment deconvolution and weight estimation of tumor samples using DECODER
Peng, X. L., Moffitt, R. A., Torphy, R. J., Volmar, K. E., & Yeh, J. J. (2019) · Nature Communications · doi:10.1038/s41467-019-12517-7 · Cited by 65
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment
Zhang, F.-P., Huang, Y., Luo, W., Deng, W., Liu, C., Xu, L., & Liu, C. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i2.134 · Cited by 62
Zhang, X., Zhao, H., Shi, X., Jia, X., & Yang, Y. (2020) · Aging · doi:10.18632/aging.202317 · Cited by 68
“Immune or stromal scores were calculated based on a comprehensive score of all genes in the tissue [14].”
MethodLi, Y., Mo, H., Wu, S., Liu, X., & Tu, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.801959 · Cited by 70
“Firstly, we used the ESTIMATE algorithm to calculate the stromal score of all samples (Yoshihara et al., 2013).”
MethodXu, M., Lu, J., Zhong, Y., Jiang, J., Shen, Y., Su, J., & Lin, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.870914 · Cited by 73
“org 5 We calculated the stromal score and immune score through the Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE) algorithm (31).”
MethodCheng, T., Wu, Y., Liu, Z., Yu, Y., Sun, S., Guo, M., Sun, B., & Huang, C. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970950 · Cited by 63
“The ESTIMATE approach calculated the stromal, immune, and ESTIMATE scores of three groups, predicting the level of stromal cells and infiltrating immune, which constructed the basis of tumor purity (22).”
BackgroundMethodZheng, X., Ma, Y., Bai, Y., Huang, T., Lv, X., Deng, J., Wang, Z., Lian, W., Tong, Y., Zhang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984480 · Cited by 68
“The ESTIMATE R package was applied to compute immune scores and stromal scores (30), representing the enrichment scores for CRC patients.”
MethodYang, J., Zhang, N., Luo, T., Yang, M., Shen, W., Tan, Z., Xia, Y., Zhang, L., Zhou, X., Lei, Q., et al. (2024) · iMeta · doi:10.1002/imt2.231 · Cited by 68
“GTEx, genotype ‐ tissue expression; TCGA, the cancer genome atlas. tissues using expression data (ESTIMATE) algorithm [32] to evaluate the ImmuneScore (the proportion of immune cells) and TumorPurity (the proportion of tumor components) across 33 cancer types in The Cancer Genome Atlas (TCGA).”
MethodCancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Gong, L., Luo, J., Yang, E., Ru, B., Qi, Z., Yang, Y., Rani, A., Purohit, A., Zhang, Y., Guan, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.004 · Cited by 59
Ageing, immune fitness and cancer
Dolan, M., Libby, K. A., Ringel, A. E., van Galen, P., & McAllister, S. S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00858-z · Cited by 62
Wang, N., Gong, T., Clarke, R. C., Chen, L., Shih, I., Zhang, Z., Levine, D. A., Xuan, J., & Wang, Y. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu607 · Cited by 68
Self-citationJhaveri, K. L., Teplinsky, E., Silvera, D., Valeta-Magara, A., Arju, R., Giashuddin, S. M., Sarfraz, Y., Alexander, M., Darvishian, F., Levine, P. H., et al. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.11.006 · Cited by 59
The tumor microenvironment in renal cell cancer
Mier, J. W. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000512 · Cited by 66
“Perhaps more than any other tumor type, ccRCC are infiltrated with T cells of various phenotype and function [1,2].”
Luo, J., Xie, Y., Zheng, Y., Wang, C., Qi, F., Hu, J., & Xu, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.2983 · Cited by 63
Molecular subtyping reveals immune alterations in IDH wild‐type lower‐grade diffuse glioma
Wu, F., Li, G., Liu, H., Zhao, Z., Chai, R., Liu, Y., Jiang, H., Zhai, Y., Feng, Y., Li, R., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5468 · Cited by 74
“The ESTIMATE algorithm was performed to calculate the fraction of stromal and immune cells with R package ‘estimate’, and tumor purity of each patient was inferred based on the formula described by Yoshihara et al [31].”
MethodLi, J., Wu, F., Li, C., Sun, S., Feng, C., Wu, H., Chen, X., Wang, W., Zhang, Y., Liu, M., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.977322 · Cited by 64
“Immune, stromal, and tumor purity scores were evaluated with the ESTIMATE algorithm (Yoshihara et al., 2013).”
MethodHyeon, D. Y., Nam, D., Han, Y., Kim, D. K., Kim, G., Kim, D., Bae, J., Back, S., Mun, D., Madar, I. H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00479-7 · Cited by 59
Self-citationFAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
Chi, H., Gao, X., Xia, Z., Yu, W., Yin, X., Pan, Y., Peng, G., Mao, X., Teichmann, A. T., Zhang, J., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1200335 · Cited by 64
“The Estimate algorithm was utilized to evaluate the composition of the tumor microenvironment (TME) for each UCEC sample, including the immune score, stromal score, and estimate cell infiltration (Yoshihara et al., 2013).”
MethodDai, L., Fan, G., Xie, T., Li, L., Tang, L. M., Chen, H., Shi, Y., & Xiao-hong, H. (2024) · Biomarker Research · doi:10.1186/s40364-024-00605-w · Cited by 64
“ESTIMATE package [42] (v 1.0.13) was used to calculate the stromal and immune content (stromal score, immune score, and ESTIMATE score) in all patients with DLBCL.”
MethodInfluentialMååg, J. L. V., Fisher, O. M., Levert‐Mignon, A., Kaczorowski, D. C., Thomas, M. L., Hussey, D. J., Watson, D. I., Wettstein, A. R., Bobryshev, Y. V., Edwards, M., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0332 · Cited by 58
“This lack of correlation of computational purity and histopathologic estimates is consistent with previous reports (26).”
ResultNg, J. C.-F., Quist, J., Grigoriadis, A. E., Malim, M. H., & Fraternali, F. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1316 · Cited by 61
Cao, J., Yang, X. L., Li, J., Wu, H., Li, P., Yao, Z., Dong, Z., & Tian, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01533 · Cited by 62
Meng, J., Lu, X., Zhou, Y., Zhang, M., Ge, Q., Zhou, J., Hao, Z., Gao, S., Yan, F., & Liang, C. Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.001 · Cited by 62
“The immune module was selected, with the gathering of patients with the highest immune enrichment score, which was estimated by ssGSEA.(61) Then, the top 150 exemplar genes with the highest weight in the immune module were extracted as the key genes to dichotomize the immune and non-immune classes, which were further…”
Chen, M., Chen, R., Jin, Y., Li, J., Hu, X. Y., Zhang, J., Fujimoto, J., Hubert, S. M., Gay, C. M., Zhu, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26821-8 · Cited by 59
Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice
Ragusa, S., Prat-Luri, B., González-Loyola, A., Nassiri, S., Squadrito, M. L., Guichard, A., Cavin, S., Gjorevski, N., Barras, D., Marra, G., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129558 · Cited by 56
Zhao, Y., Xu, L., Wang, X., Niu, S., Chen, H., & Li, C. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12902 · Cited by 62
Li, J., Qiao, H., Wu, F., Sun, S., Feng, C., Li, C., Yan, W., Lv, W., Wu, H., Liu, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998140 · Cited by 62
“ESTIMATE is an algorithm used to estimate immune cells, stromal cells, and tumor purity (52).”
MethodZhang, D., Lü, W., Cui, S., Mei, H., Wu, X., & Zhuo, Z. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01059-0 · Cited by 59
“By using the expression data, an estimate algorithm can predict the score of stromal cells and immune cells, and the tumor purity in each tumor sample can then be calculated [25].”
MethodYuan, Q., Zhang, W., & Shang, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1045167 · Cited by 56
“The “estimate” algorithm was developed by Kosuke et al (20).”
MethodHPV‐related methylation‐based reclassification and risk stratification of cervical cancer
Yang, S., Wu, Y., Wang, S., Xu, P., Deng, Y., Wang, M., Liu, K., Tian, T., Zhu, Y., Li, N., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12709 · Cited by 60
Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
Chai, A. W. Y., Yee, P. S., Price, S., Yee, S. M., Lee, H. M., Tiong, V. K., Gonçalves, E., Behan, F. M., Bateson, J., Gilbert, J. G. R., et al. (2020) · eLife · doi:10.7554/elife.57761 · Cited by 59
Li, J., Li, L., You, P., Wei, Y., & Xu, B. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.009 · Cited by 55
Zhou, R., Zeng, D., Zhang, J., Sun, H., Wu, J., Li, N., Li, L., Shi, M., Bin, J., Liao, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.043 · Cited by 60
Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
Liang, J., Zhi, Y., Deng, W., Zhou, W., Li, X., Cai, Z., Zhu, Z., Zeng, J., Wu, W., Dong, Y., et al. (2021) · PeerJ · doi:10.7717/peerj.11627 · Cited by 60
Yang, M., Lin, C.-H., Wang, Y., Chen, K., Zhang, H., & Li, W. (2022) · Genome Medicine · doi:10.1186/s13073-022-01079-x · Cited by 61
“Virtual microdissection analytical approach based on non-negative matrix factorization (NMF) has enabled effective deconvolution on the gene expression signals derived from tumour cells, inflammatory cells, stromal cells, and cytokines from bulk tumour samples [12, 13].”
MethodSobral, D., Martins, M., Kaplan, S., Golkaram, M., Salmans, M., Khan, N., Vijayaraghavan, R., Casimiro, S., Fernandes, A., Borralho, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03884-x · Cited by 63
Sun, Q., Ye, H., He, J., Wang, J., Ma, X., Ning, Q., Zhao, Q., Jin, Q., Yang, L., Li, S., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01226-y · Cited by 63
“To analyze the correlation between tumor microenvironment and alternative splicing, we employed the estimate to characterize the stromal and immune cell infiltration [45], and then analyzed the correlation between CRC microenvironment and splicing alterations in CRC samples.”
MethodInfluentialZhang, P., Zhang, H., Tang, J., Ren, Q., Zhang, J., Chi, H., Xiong, J., Gong, X., Wang, W. T., Lin, H., et al. (2023) · Aging · doi:10.18632/aging.205077 · Cited by 58
“In parallel, the assessment of immunological scores, Stromal Scores, and ESTIMATE Scores for the LUAD patient cohort was executed via the utilization of the “estimate” R package [39].”
MethodZhang, L., Cui, Y., Mei, J., Zhang, Z., & Zhang, P. (2024) · Cell Proliferation · doi:10.1111/cpr.13703 · Cited by 65
“In addition, we judiciously utilized the specific features of the ‘ estimate ’ R package 27 to quantify immune scores, stromal scores and ESTIMATE scores for TCGA-LUAD patients, enabling a comprehensive evaluation of the TME.”
MethodTumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
Wei, C., Ma, Y., Wang, M., Wang, S., Yu, W., Dong, S., Deng, W., Bie, L., Zhang, C., Shen, W., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00660-4 · Cited by 63
“Tostratifyvarioustypesofcancerbasedonpro-in fl am and pro-tumor TAMs, we used RNA-seq data from a cohort of 9164 TCGA tumors across 32cancertypes.”
MethodInfluentialThe Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis
Yang, S., Liu, H., Zheng, Y., Chu, H., Lu, Z., Yuan, J., & Xu, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s509245 · Cited by 57
“30 The influence of PLIN3 on the tumor microenvironment was assessed by calculating the Immune Score, Stromal Score, ESTIMATE Score, and tumor purity using the “Estimate” package in R. 31 The relationship between PLIN3 levels and six immune subtypes was analyzed using the TISDB Subtype module.”
Wen, W. X., Soo, J. S.-S., Kwan, P. Y., Hong, E., Khang, T. F., Mariapun, S., Lee, C. S. M., Hasan, S. N., Rajadurai, P., Yip, C. H., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0717-1 · Cited by 61
“Immune scores for breast cancers from TCGA and METABRIC datasets were defined using the Estimation of STromal and Immune cell in MAlignant Tumour (ESTIMATE) tissues using Expression data algorithm [23].”
MethodMouriaux, F., Zaniolo, K., Bergeron, M., Weidmann, C., de la Fouchardière, A., Fournier, F., Droit, A., Morcos, M., Landreville, S., & Guérin, S. L. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19317 · Cited by 61
Zhuang, Y., Wang, H., Jiang, D., Li, Y., Feng, L., Tian, C., Pu, M., Wang, X., Zhang, J., Hu, Y., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08108-9 · Cited by 54
Lu, T., Xu, R., Li, Q., Zhao, J., Peng, B., Zhang, H., Guo, J., Zhang, S., Li, H.-W., Wang, J., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.011 · Cited by 65
“39 Here, we used the R package “ estimate ” to calculate the immune score and used Kaplan-Meier survival curves to evaluate the relationship between immune score and patients ’ survival in TCGA-ESCC dataset.”
Liu, Z., Liu, J., Liu, X., Wang, X., Xie, Q., Zhang, X., Kong, X., He, M., Yang, Y., Deng, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab860 · Cited by 74
“One advantage of patient samples is that they can reflect the TME to some extent (47,48), and therefore this analysis is designed to reveal TME factors potentially associated with the drug resistance.”
Wang, H., Liu, J., Jiang, Y., Wang, Z., Zhang, Z., Peng, J., Wang, Y., & Li, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943389 · Cited by 67
“Immune scores, stromal scores, and tumor purity were calculated using the ESTIMATE algorithm (24), which was provided in the “estimate” R package.”
MethodXie, H., Shi, M., Liu, Y., Cheng, C., Song, L., Ding, Z., Jin, H., Cui, X., Wang, Y., Yao, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914977 · Cited by 57
“Second, the estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) was used to assess the purity of tumors according to the analysis of stromal and immune cells (33).”
MethodProteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Tong, Y., Sun, M., Chen, L., Wang, Y., Yan, L., Li, L., Zhang, X., Cai, Y., Qie, J., Pang, Y., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01384-3 · Cited by 57
“Neoplastic cellularity was evaluated independently by whole-exome sequencing using the ABSOLUTE [79] and ESTIMATE [78] algorithm (Methods) and ranged from 10 to 60% (median 36%), 1% to 70% (median 50%), respectively (Additional file 23: Table S1B).”
MethodInfluentialOh, J., An, M., Son, D., Choi, J., Cho, Y. B., Yoo, C. E., & Park, W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00892-z · Cited by 59
Radiomics for characterization of the glioma immune microenvironment
Khalili, N., Kazerooni, A. F., Familiar, A., Haldar, D., Kraya, A., Foster, J., Koptyra, M., Storm, P. B., Resnick, A. C., & Nabavizadeh, A. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00413-9 · Cited by 60
Chang, L., Liu, J., Zhu, J., Guo, S., Wang, Y., Zhou, Z., & Wei, X. (2025) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2024.0376 · Cited by 101
“ESTIMATE, a method used for inferring the proportions of stromal cells and immune cells in tumor samples 42 , enables pancancer immune infiltration analysis via data from public databases such as TCGA.”
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas
Tosolini, M., Algans, C., Pont, F., Ycart, B., & Fournié, J. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1188246 · Cited by 55
“Fourth, leucocyte infiltration of cancer biopsies can be assessed by the gene expression-based quantification of 22 gene sets composed of differentially-expressed genes (known as TM22).(14,18,23)”
BackgroundMethodRole of COL6A3 in colorectal cancer
Liu, W., Li, L., Ye, H., Tao, H., & He, H. (2018) · Oncology Reports · doi:10.3892/or.2018.6331 · Cited by 62
“The transcriptome data were analyzed using the ESTIMATE bioinformatics tool (31), and it was indicated that the stroma contributes to the survival of patients with CRC (Fig.”
BackgroundMethodDigitaldlsorter: Deep-Learning on scRNA-Seq to Deconvolute Gene Expression Data
Torroja, C., & Sánchez‐Cabo, F. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00978 · Cited by 59
“For EPIC, MCPCounter and ESTIMATE methods we used standard approaches as described in their respective R packages (https://github.com/GfellerLab/EPIC, https://github.com/ebecht/ MCPcounter, https://bioinformatics.mdanderson.org/estimate/ index.html).”
InfluentialYue, H., Wang, J., Chen, R., Hou, X., Li, J., & Lü, X. (2019) · BMC Cancer · doi:10.1186/s12885-019-6470-y · Cited by 62
Bocci, M., Sjölund, J., Kurzejamska, E., Lindgren, D., Marzouka, N., Bartoschek, M., Höglund, M., & Pietras, K. (2018) · Angiogenesis · doi:10.1007/s10456-018-9642-5 · Cited by 58
“Finally, the 8-gene signature also showed good concordance with the stromal signature developed to estimate the level of infiltration in bladder tumors [28] (Fig.”
MethodPark, S., Joung, J., Min, Y. W., Nam, J., Ryu, D., Oh, D., Park, W., Lee, S. K., Choi, Y., Ahn, J. S., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0609-x · Cited by 57
Zhang, Z., Li, J., He, T., & Ding, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00330 · Cited by 59
“Immune-related genes could be used to calculate the immune scores and evaluate the tumor infiltration of immune cells to analyze the tumor immune characteristics (10).”
BackgroundIdentification of prognostic genes in uveal melanoma microenvironment
Luo, H., & Ma, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242263 · Cited by 72
“Among the 21 prognostic genes found in this study, 7 genes (SERPINB9, HFE, IL12RB2, MTUS1, NEDD9, GEM, and SLCO5A1) were located in the chromosomes as mentioned above (Table 2).”
MethodInfluentialQiu, P., Guo, Q., Yao, Q., Chen, J., & Lin, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.736030 · Cited by 58
“org 3 stromal score, and ESTIMATE score (37).”
BackgroundMethodLncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
Song, Z., Wang, X., Chen, F., Chen, Q., Liu, W., Yang, X., Zhu, X., Liu, X., & Wang, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1004212 · Cited by 55
“Immune score, stromal score, and tumor purity of each sample were calculated by using the ESTIMATE algorithm (30).”
MethodTurning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC
Xie, J., Zheng, S., Zou, Y., Tang, Y., Tian, W., Wong, C., Wu, S., Ou, X., Zhao, W., Cai, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022147 · Cited by 60
“In addition, we applied the ESTIMATE algorithm to obtain the immune and stromal scores of each patient (24).”
MethodBST2 induced macrophage M2 polarization to promote the progression of colorectal cancer
He, X., Chen, H., Zhong, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., Shi, D., & Li, D. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72538 · Cited by 55
“For the purpose of immune and stromal score calculation [22], a total of 480 TCGA-COAD patients were included in our study.”
CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma
Wang, S., Wu, Z., Zhu, S., Wan, S., Zhang, M.-J., Zhang, B., Yang, Q., Xiao, Y., Li, H., Mao, L., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.023 · Cited by 58
Noninvasive radiomics model reveals macrophage infiltration in glioma
Fan, X., Li, J., Huang, B., Lu, H., Lu, C., Pan, M., Wang, X., Zhang, H., You, Y., Wang, X., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216380 · Cited by 54
Xu, S., Zheng, Y., Ye, M., Shen, T., Zhang, D., Li, Z., & Lu, Z. (2024) · BMC Cancer · doi:10.1186/s12885-024-12843-0 · Cited by 54
“We utilized the ESTIMATE algorithm to calculate the Immune, Stromal, and ESTIMATE scores across pan-cancer [35, 36].”
MethodZhang, S., Jing, Y., Zhang, M., Zhang, Z., Ma, P., Peng, H., Shi, K., Gao, W., & Zhuang, G. (2015) · Scientific Reports · doi:10.1038/srep16066 · Cited by 56
The prognostic potential of alternative transcript isoforms across human tumors
Trincado, J. L., Sebestyén, E., Pagés, A., & Eyras, E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0339-3 · Cited by 63
“To estimate a stromal and immune signature for a set of samples from a tumor type, we collected a list of stromal and immune signature genes based on [18].”
BackgroundMethodSchwede, M., Waldron, L., Mok, S. C., Wei, W., Basunia, A., Merritt, M. A., Mitsiades, C. S., Parmigiani, G., Harrington, D. P., Quackenbush, J. F., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1359 · Cited by 55
“Deconvolution of cell mixtures in bulk gene-expression studies is an active area of research (41), and we identified tissue-specific marker genes of HGSOC epithelial carcinoma and stroma (Supplementary Table S2) that may be applied to computational prediction of cell proportions and in the study of tumor/stroma intera…”
BackgroundXiong, Y., Wang, Z., Zhou, Q., Zeng, H., Zhang, H., Liu, Z., Huang, Q., Wang, J., Chang, Y., Xia, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000447 · Cited by 63
“Using ESTIMATE, 16 we found that TMEcluster-B had higher Immune Score (p 0.001), a marker of total immune infiltration (figure 2E).”
InfluentialImmune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
Wang, Y., Chen, L., Yu, M., Fang, Y., Qian, K., Wang, G., Ju, L., Xiao, Y., & Wang, X. (2020) · Cancer Medicine · doi:10.1002/cam4.3400 · Cited by 61
Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer
Jiang, X., Yan, Q., Xie, L., Xu, S., Jiang, K., Huang, J., Wen, Y., Yan, Y., Zheng, J., Tang, S., et al. (2021) · Journal of Oncology · doi:10.1155/2021/6635526 · Cited by 58
“presence of stroma), and ESTIMATE Score (reflecting the sum of both) [19].”
BackgroundYin, X., Wang, Z., Wang, J., Xu, Y., Kong, W., & Zhang, J. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1933332 · Cited by 69
METTL9 mediated N1-histidine methylation of zinc transporters is required for tumor growth
Lv, M., Cao, D., Zhang, L., Hu, C., Li, S., Zhang, P., Zhu, L., Yi, X., Li, C., Yang, A., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00857-4 · Cited by 58
Zhang, W., Yao, S., Huang, H., Zhou, H., Zhou, H., Wei, Q., Bian, T., Sun, H., Li, X., Zhang, J., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1959977 · Cited by 58
“And we used the R package of estimate to evaluate the immune score and ESTIMATE score of each patient.(23)”
MethodIntegrative multiomics-histopathology analysis for breast cancer classification
Ektefaie, Y., Yuan, W., Dillon, D. A., Lin, N. U., Golden, J. A., Kohane, I. S., & Yu, K.-H. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00357-y · Cited by 49
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
Yue, Y., Zhang, Q., & Sun, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758040 · Cited by 58
“We performed ssGSEA method for each sample, and the immune infiltration (ImmuneScore), overall stromal content (StromalScore), and the combined (EstimateScore) were calculated by ESTIMATE algorithms (21).”
MethodTumor-Infiltrating CD8 T Cells Predict Clinical Breast Cancer Outcomes in Young Women
Jin, Y. W., & Hu, P. (2020) · Cancers · doi:10.3390/cancers12051076 · Cited by 57
Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma
Yan, G., An, Y., Xu, B., Wang, N., Sun, X., & Sun, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.670490 · Cited by 58
“It was applied to evaluate the tumor microenvironment (TME) of each patient with COAD, along with stromal score (stromal content), immune score (extent of immune cell infiltration), ESTIMATE score (synthetic mark of stroma and immune), and tumor purity by R package estimate (23).”
MethodLi, L., Xie, R., & Lu, G. (2021) · Bioscience Reports · doi:10.1042/bsr20210760 · Cited by 57
Ye, Z., Zou, S., Niu, Z., Xu, Z., & Hu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691676 · Cited by 60
“Immune Analysis The estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) method was applied to calculate the immune score, ESTIMATE score, and tumor purity of the patients, via the R package “estimate” (Yoshihara et al., 2013).”
MethodPrognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
Chen, X., Yang, L., Jin, L., Lin, W., Zhang, F., Huang, S., & Huang, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.962028 · Cited by 54
“The R package “ESTIMATE” is used to calculate StromalScore, ImmuneScore, and ESTIMATEScore, which is the sum of ImmuneScore and StromalScore (Yoshihara et al., 2013; Lv et al., 2021).”
MethodHosen, S. M. Z., Uddin, M. N., Xu, Z., Buckley, B. J., Perera, C. J., Pang, T., Mekapogu, A. R., Moni, M. A., Notta, F., Gallinger, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1060957 · Cited by 60
“Since the infiltration levels of immune cells are an independent predictor of survival in cancers (58), the differences in various immune and stromal signatures between PLAU-high and PLAU-low patients in the TCGA-PDAC cohort were examined.”
BackgroundMethodInfluentialAndrieux, G., Das, T., Griffin, M., Straehle, J., Paine, S., Beck, J., Boerries, M., Heiland, D. H., Smith, S. J., Rahman, R., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01207-1 · Cited by 55
“Interestingly, a link between an MES gene signature and decreased tumor purity has been established as a common theme across different cancers [73, 74].”
BackgroundZhang, P., Zhang, X., Cui, Y., Gong, Z., Wang, W. T., & Lin, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244144 · Cited by 57
“Additionally, the immunological scores, stromal scores, and ESTIMATE scores of LUAD patients were calculated using the “estimate” R package (33).”
MethodJacobs, C. L., Shah, S., Lu, W., Ray, H., Wang, J., Hockaden, N., Sandusky, G. E., Nephew, K. P., Lü, X., Cao, S., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0902 · Cited by 55
“Breast cancer has historically thought to be a low immunogenic tumor (3).”
BackgroundHuang, T.-X., Huang, H.-S., Dong, S., Chen, J., Zhang, B., Li, H., Zhang, T., Xie, Q., Long, Q., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50077-7 · Cited by 56
“Q14 : In Fig.5, authors should knockdown Rab7a so as to demonstrate that it is required for regulating Tgfβ1 expression in tumor cells.”
Sivakumar, S., de Santiago, I., Chlon, L., & Markowetz, F. M. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002223 · Cited by 53
Heindl, A., Khan, A. M., Rodrigues, D. N., Eason, K., Sadanandam, A., Orbegoso, C., Punta, M., Sottoriva, A., Lise, S., Banerjee, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06130-3 · Cited by 46
CD3D is Associated with Immune Checkpoints and Predicts Favorable Clinical Outcome in Colon Cancer
Yang, Y., Zang, Y., Zheng, C., Li, Z., Gu, X., Zhou, M., Wang, Z., Xiang, J., Chen, Z., & Zhou, Y. (2020) · Immunotherapy · doi:10.2217/imt-2019-0145 · Cited by 53
Ren, Q., Zhu, P., Zhang, H., Ye, T., Liu, D., Gong, Z., & Xia, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01173-3 · Cited by 61
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.